Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Neutral Schroders (SDR) by JP Morgan
- Sell Jaywing (JWNG) by Steve Moore in ShareProphets
- Sell Jubilee Metals Group (JLP) by Tom Winnifrith in ShareProphets
- Sell Jubilee Metals Group (JLP) by Steve Moore in ShareProphets
- Sell Tribe Technology (TRYB) by Steve Moore in ShareProphets
- Outperform Hollywood Bowl Group (BOWL) by RBC Capital
- Buy JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
- Hold Legal & General Group (LGEN) by Harvey Jones in The Motley Fool
- Sell Gelion (GELN) by Steve Moore in ShareProphets
- Buy GSK (GSK) by Harvey Jones in The Motley Fool
- Neutral Synthomer (SYNT) by UBS
- Neutral Carvana Co Class A (0A79) by UBS
- Equal Weight United Utilities Group (UU.) by Barclays
- Overweight Workspace Group (WKP) by Barclays
- Equal Weight Safestore Holdings (SAFE) by Barclays
- Equal Weight Severn Trent (SVT) by Barclays
- Overweight Pennon Group (PNN) by Barclays
- Overweight Land Securities Group (LAND) by Barclays
- Overweight LondonMetric Property (LMP) by Barclays
- Overweight Convatec Group (CTEC) by Barclays
Valirx (VAL) Share Price
Health Care Sector
NOTE: This is based on 6 open tips for Valirx (VAL)
| Latest Bid : 0.70p | Latest Ask : 0.75p |
| High Today : 0.75p | Low Today : 0.70p |
| This Years High : 6.15p | This Years Low : 0.70p |
| Volume : 171,119 | MKT Cap : £0.95M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Valirx (VAL) Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.Valirx (VAL) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |
Valirx (VAL) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.70p | Latest Ask : 0.75p |
| High Today : 0.75p | Low Today : 0.70p |
| This Years High : 6.15p | This Years Low : 0.70p |
| Volume : 171,119 | MKT Cap : £0.95M |
Valirx Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Valirx Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |